31JUL

Modo Energy's £12.7m came from a bank

1 min read

12:32UTC

Modo Energy raised £12.7m on 22 July from CIBC Innovation Banking, a lending arm rather than a venture fund.

← Back to Humanoid hit $1.35bn on a customer order Jump to analysis ↓

TechnologyDeveloping

Key takeaway

Modo Energy borrowed rather than sold equity, which a subscription data business can do and most startups cannot.

Modo Energy, a UK energy market data company, raised £12.7 million on Wednesday 22 July from CIBC Innovation Banking, the Canadian bank's technology lending arm⁠¹. The weekly roundup names no other backer.

A venture fund buys equity and prices the company doing it. A bank's innovation desk lends against revenue, usually with a warrant attached and covenants that a fund would not impose. The weekly roundup does not split the two, so treat the £12.7 million as capital raised rather than as a valuation event⁠².

Which instrument a company picks says something about what it sells. Debt suits recurring subscription revenue that a lender can underwrite, and a data business billing energy traders and asset owners month after month fits that description better than most startups do. Founders who can borrow at this stage keep their equity; founders who cannot, sell it.

The bulk of last year's UK deal count sat in this band rather than in the growth rounds that set the headlines. Lenders have been quietly taking a larger share of it, and a round backed only by a bank leaves no valuation behind for the next investor to argue with.

Deep Analysis

In plain English

Modo Energy sells data about the energy market to businesses. Instead of selling shares in the company to investors, the way most startups raise money, it borrowed £12.7m from CIBC Innovation Banking, the technology-lending arm of a Canadian bank. This kind of loan is different from the venture capital rounds covered elsewhere in this update: the company must pay the money back on a schedule, but its existing owners do not have to give up any ownership stake to get it.

Deep Analysis

Root Causes

Venture lenders like CIBC Innovation Banking price debt against a company's recurring subscription revenue rather than against a story about future growth.

The facility suits Modo Energy specifically because its energy-market data product bills customers on a recurring basis; a pre-revenue or lumpy-revenue hardware company could not qualify for the same lending structure regardless of how promising its technology.

What could happen next?

Meaning
Modo Energy's use of venture debt rather than equity signals the company already generates predictable recurring revenue, since lenders require that revenue base before extending this type of facility.

Sources:UKTN

Mentions:GOI Energy →CIBC Innovation Banking →Modo Energy →

First Reported In

Update #13 · Humanoid hit $1.35bn on a customer order

UKTN· 31 Jul 2026

Read original →

Different Perspectives

Abu Dhabi Investment Council

The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.

CDP Venture Capital

CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.

EDBI

Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.

Forbion

Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.

British Business Bank

The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.

Stryker Corporation

Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.